A detailed history of Qube Research & Technologies LTD transactions in Rezolute, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 126,965 shares of RZLT stock, worth $543,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,965
Previous 1,231 10213.97%
Holding current value
$543,410
Previous $5,000 12200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $519,281 - $667,647
125,734 Added 10213.97%
126,965 $615,000
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $2,814 - $7,115
1,229 Added 61450.0%
1,231 $5,000
Q3 2023

Nov 13, 2023

BUY
$1.32 - $2.1 $2 - $4
2 New
2 $0

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $166M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.